Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Novo Nordisk A/S

10 clinical trials · 10 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Novo Nordisk A/S

RECRUITINGPhase 3NCT06118281

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development...

Sponsor: Novo Nordisk A/SEnrolling: 1000020 locations
Cardiovascular RiskAcute Myocardial Infarction (AMI)
RECRUITINGPhase 3NCT07076199

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily...

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with...

Sponsor: Novo Nordisk A/SEnrolling: 87720 locations
Diabetes Mellitus, Type 1
RECRUITINGPhase 1NCT07270731

A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes

This study is testing a new medicine that might help treat people with type 2 diabetes. The study is conducted to see if the new medicine can lower high sugar levels in the blood....

Sponsor: Novo Nordisk A/SEnrolling: 721 location
Healthy VolunteerType 2 Diabetes
RECRUITINGPhase 1NCT06719011

A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

This study is testing a new study medicine to treat people living with overweight or obesity. The aim of this study is to see if the medicine is safe, how it works in human body,...

Sponsor: Novo Nordisk A/SEnrolling: 1772 locations
ObesityOverweight
RECRUITINGPhase 3NCT06609226

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are inherited blood...

Sponsor: Novo Nordisk A/SEnrolling: 48020 locations
Sickle Cell DiseaseThalassemia
RECRUITINGNCT05621746

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

This study will collect information on the long term health of joints in people with haemophilia A who have started treatment with Esperoct within twelve months prior to...

Sponsor: Novo Nordisk A/SEnrolling: 1001 location
Haemophilia A
RECRUITINGPhase 1NCT07238816

A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People

The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it is absorbed in the...

Sponsor: Novo Nordisk A/SEnrolling: 801 location
Haemophilia A
RECRUITINGNCT06574984

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

The study has descriptive purposes, with aim of assessing how turoctocog alfa is used in the everyday practice and to provide a baseline for the management of haemophilia A and...

Sponsor: Novo Nordisk A/SEnrolling: 9007 locations
Congenital Bleeding DisorderHaemophilia A
RECRUITINGPhase 1NCT07220564

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

This study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8 is safe to use for...

Sponsor: Novo Nordisk A/SEnrolling: 3020 locations
Haemophilia A
RECRUITINGPhase 3NCT07207811

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in...

This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition called transthyretin...

Sponsor: Novo Nordisk A/SEnrolling: 128020 locations
Transthyretin Amyloid Cardiomyopathy (ATTR CM)